TRL.F DaVita Inc

Healthcare Health Care Providers & Services Frankfurt Exchange
157.85 EUR
Close of Nov 12, 2026
86.70 211.70
Market cap
EUR 9.93B
P/E
13.9x
P/B
21.60x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is TRL.F undervalued?

Graham number

The Graham number of DaVita Inc cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

DaVita Inc fundamental analysis

No fundamental analysis for DaVita Inc yet.

DaVita Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and ma…

Full company profile